Mark Gergen

Mark Gergen

No open positions remaining
63 year
Health Technology
Commercial Services
Consumer Services

Profile

Mark J.
Gergen
is an Independent Director at Aristea Therapeutics, Inc. He previously served as the Executive Chairman at Poseida Therapeutics, Inc. from 2024 to 2025.
Mark also held positions as a Director at Aperio Technologies, Inc., Chief Financial & Development Officer at Advanced Tissue Sciences, Inc. from 1999 to 2003, and Senior Vice President-Corporate Development at Amylin Pharmaceuticals, Inc. from 2005 to 2012.
He was also a Principal at Jostens, Inc. and Medtronic, Inc. Mark served as the Chief Operating Officer & Senior Vice President at Halozyme Therapeutics, Inc. from 2016 to 2017, and as the Executive Vice President at CardioNet LLC from 2003 to 2005.
He was also a Principal at Premier Healthcare Solutions, Inc. and served as the Chief Operating Officer, Secretary & Executive VP at Mirati Therapeutics, Inc. in 2016.
Mr. Gergen obtained his undergraduate degree from Minot State University and his graduate degree from The University of Minnesota Law School.

Former positions of Mark Gergen

CompaniesPositionEnd
POSEIDA THERAPEUTICS, INC. Chief Executive Officer 01/01/2024
HALOZYME THERAPEUTICS, INC. Chief Operating Officer 29/09/2017
MIRATI THERAPEUTICS Chief Operating Officer 16/09/2016
Corporate Officer/Principal 01/11/2012
Corporate Officer/Principal 01/03/2005
See the detail of Mark Gergen's experience

Training of Mark Gergen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology